Alteration of pharmacokinetics of lepirudin caused by anti-lepirudin antibodies occurring after long-term subcutaneous treatment in a patient with recurrent VTE due to Behcets disease.

Linnemann, B

Alteration of pharmacokinetics of lepirudin caused by anti-lepirudin antibodies occurring after long-term subcutaneous treatment in a patient with recurrent VTE due to Behcets disease. [electronic resource] - VASA. Zeitschrift fur Gefasskrankheiten Feb 2010 - 103-7 p. digital

Publication Type: Case Reports; Journal Article

0301-1526

10.1024/0301-1526/a000012 doi


Adult
Antibodies--blood
Anticoagulants--adverse effects
Behcet Syndrome--complications
Dose-Response Relationship, Drug
Female
Heparin--therapeutic use
Hirudins--adverse effects
Humans
Recombinant Proteins--adverse effects
Recurrence
Venous Thromboembolism--drug therapy